HiRO - Harvest Integrated Research Organization’s Post

Choosing the right location can be the key to a successful clinical trial. Here’s why Thailand should be at the top of your list: 1️⃣ Cost-Effectiveness: Conduct rigorous trials at a fraction of the cost without compromising quality. 2️⃣ Diverse Patient Population: Access a wide range of genetic backgrounds, boosting the relevance and generalizability of your study. 3️⃣ Efficient Regulatory Process: Get faster approvals with Thailand’s streamlined regulatory environment. Want to know the other four reasons? Click the link to dive deeper into why Thailand is the ideal choice for your clinical research!🚀 https://lnkd.in/gxkrPh-i #ClinicalTrials #Research #Thailand #HealthcareInnovation #PharmaResearch

Choosing the right location can be the key to a successful clinical trial. Here’s why Thailand should be at the top of your list: 1️⃣ Cost-Effectiveness: Conduct rigorous trials at a fraction of the cost without compromising quality. 2️⃣ Diverse Patient Population: Access a wide range of genetic backgrounds, boosting the relevance and generalizability of your study. 3️⃣ Efficient Regulatory Process: Get faster approvals with Thailand’s streamlined regulatory environment. Want to know the other four reasons? Click the link to dive deeper into why Thailand is the ideal choice for your clinical research!🚀 https://lnkd.in/gwMWydvp #ClinicalTrials #Research #Thailand #HealthcareInnovation #PharmaResearch

Choosing the right location can be the key to a successful clinical trial. Here’s why Thailand should be at the top of your list: 1️⃣ Cost-Effectiveness: Conduct rigorous trials at a fraction of the cost without compromising quality. 2️⃣ Diverse Patient Population: Access a wide range of genetic backgrounds, boosting the relevance and generalizability of your study. 3️⃣ Efficient Regulatory Process: Get faster approvals with Thailand’s streamlined regulatory environment. Want to know the other four reasons? Click the link to dive deeper into why Thailand is the ideal choice for your clinical research!🚀 https://lnkd.in/gjys7WBe #ClinicalTrials #Research #Thailand #HealthcareInnovation #PharmaResearch

Choosing the right location can be the key to a successful clinical trial. Here’s why Thailand should be at the top of your list: 1️⃣ Cost-Effectiveness: Conduct rigorous trials at a fraction of the cost without compromising quality. 2️⃣ Diverse Patient Population: Access a wide range of genetic backgrounds, boosting the relevance and generalizability of your study. 3️⃣ Efficient Regulatory Process: Get faster approvals with Thailand’s streamlined regulatory environment. Want to know the other four reasons? Click the link to dive deeper into why Thailand is the ideal choice for your clinical research!🚀 https://lnkd.in/dBkus88b #ClinicalTrials #Research #Thailand #HealthcareInnovation #PharmaResearch

Post 10/10 Thats to everyone for following along with the past 9 posts to do with my published work. I still have lots of interesting projects in the pipeline. Those nearing the finish line (i.e. under peer review or submission due imminently) include: -A scoping review exploring pyshcosocial factors in published knee osteoarthritis research -An exploration of the self-reported quality of care of people seeking care for knee osteoarthritis in Singapore -A large-scale, multi-profession web-based survey exploring weight bias of healthcare professionals in Singapore -A content analysis of media articles reporting about the causes of falls in the over 60’s in Singapore I will share these with you all as/when they get published (fingers crossed!)

In commemorating International Clinical Trials Day, ACRA celebrates the growth and collaboration in African Clinical trials, which have grown significantly from 3% to 5% of the global trial share over the past four years. The African continent is witnessing a significant rise in clinical trials, reflecting increased investment in health research and development. The top five African countries—Egypt, South Africa, Tunisia, Uganda, and Kenya—play a pivotal role in this growth. Despite making up a small percentage of global trials, the increasing number of trials in Africa indicates the continent's potential to contribute to global health research. ACRA provides a snapshot of the current state of clinical trials in Africa and advocates the need for continued support and collaboration to enhance clinical research capabilities across the continent.

ACRA has released a report detailing the status of clinical research in Africa, showcasing substantial growth over the past four years. The report highlights that the percentage of clinical trials has notably increased, moving from three percent to five percent over the past five years, exceeding expectations. For more insights and updates, check out the full report and follow ACRA. Utano CRO

Clinical Trial Diversity: Macro Edition - Here is a breakdown of 5 major global regions and their corresponding share of population and ongoing clinical trials (%). Region Differentials: North America +18.7% Europe +9.6% South and Central America -4.7% Africa -9.6% Asian Pacific -14%

Singapore’s National Day is very much a celebration of our diversity. Unfortunately, this diversity isn't always mirrored in clinical trials. In a newly published Review Article on representativeness of participants in pharmaceutical randomised controlled trials (RCTs) conducted in Singapore, authors from Lee Kong Chian School of Medicine looked at four databases —PubMed, Embase, Cochrane Library and Web of Science — to identify pharmaceutical RCTs involving the Singapore population over 5 years from January 2017 to August 2022. Among other things, they found that females and Indians were underrepresented in clinical trials, compared to our population demographics. This is important because sex and ethnicity can influence the efficacy and safety of pharmaceutical interventions. Clinical trials are crucial for developing new and effective medications. Ensuring these trials include a representative sample of the population is essential to make sure the drugs being developed are safe and work for everyone. We can achieve this by: • Raising awareness about the importance of clinical trial participation among all communities. • Developing culturally sensitive recruitment strategies. • Partnering with community organisations to reach underrepresented populations. By working together, we can ensure that everyone in Singapore has the opportunity to participate in clinical trials and benefit from the latest medical advancements. What are your challenges as a researcher in comprehensive data reporting? #MahjulahSingapura #Singapore #ClinicalTrials #DiversityInScience NTU LKCMedicine PHD Programme

Country utilization by region has shifted significantly in the past five years with Western Europe share declining by 21% (from 32% to 25% of global total) and Eastern Europe share decreasing 33% (from 17% to 11%), as North America share increased 17% (from 19% to 23%) and China share increased 57% (from 10% to 15%).